Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 55th WMA General Assembly
October 25, 2004
- Necessary to Further Open the Way to Mixed Medical Care: Health Minister Otsuji
October 25, 2004
- Ministries to Cooperate to Develop Nanotech in Healthcare Field
October 25, 2004
- NER PRODUCTS
October 25, 2004
- Continue to Grow Above Market Level: Mr Banchi of Boehringer Ingelheim
October 25, 2004
- Council Insists on Lifting of Ban on "Mixed Medical Care"
October 25, 2004
- Roche Eager to Strengthen Presence in Japan: Mr Noguchi
October 25, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 25, 2004
- Creating a New Kind of Drug Distributor: Mediceo Holdings
October 25, 2004
- BULLETIN
October 25, 2004
- Quintiles Japan Eager to Conduct Joint Clinical Trials in Japan, Asia
October 25, 2004
- BULLETIN
October 25, 2004
- BUSINESS NEWS IN BRIEF
October 25, 2004
- Hypertension GLs Revised
October 25, 2004
- PRESS SEMINAR
October 25, 2004
- Tanabe to Begin Research Using Human ES Cells Obtained in Japan
October 25, 2004
- WEBSITE NWES
October 25, 2004
- EFPIA Survey Finds Problems in Clinical Trial Environment
October 25, 2004
- Korosho to Consider 8-Year Data Protection Period in Earnest
October 25, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 25, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…